Clinical Trial Update: Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of TPI ASM8 in allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• TPI ASM8

Snippet

Sponsor: Syntara | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED